Top Markets
#1 DogBull DogBull +54.95%
#2 Siren Siren +30.99%
#3 OriginTrail OriginTrail +18.04%
#4 龙虾 (Lobster) 龙虾 (Lobster) +10.93%
#5 Ethena Staked ENA Ethena Staked ENA +10.57%
#6 Cysic Cysic +8.95%
#7 Stargate Finance Stargate Finance +8.71%
#8 COTI COTI +7.88%
#9 Ether.fi Ether.fi +7.19%
#10 Collect on Fanable Collect on Fanable +7.11%
Coin of the day
DogBull DogBull
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ABIONYX Pharma S.A. ABIONYX Pharma S.A.

ABIONYX Pharma S.A.

ABNX
Rang in aandelen #21916
ABIONYX Pharma SA is a biotechnology company dedicated to the identification... ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.
Aandeelprijs
$2.32
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$98.03M
Verandering (1 dag)
-1.91%
Verandering (1 jaar)
-5.84%
Land
FR
Handel ABIONYX Pharma S.A. (ABNX)

Categorie

Healthcare
Dividendgeschiedenis van ABIONYX Pharma S.A. (ABNX)
ABIONYX Pharma S.A. (aandelsymbool: ABNX) heeft in totaal 0 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: 0.00
Dividendrendement (TTM): 0
Dividendbetalingen voor ABIONYX Pharma S.A. (ABNX) van 2026 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
Bedrijf Aantal dividendbetalingen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH